Bruce E Johnson - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Bruce E Johnson

Showing results (71-80 of 284) with videos related to

Pageof 29

Sort By:

European Journal of Radiology|December 12, 2018

Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigmMizuki Nishino, Satoshi Wakai, Tomoyuki Hida, et al.

JAMA Network Open|July 7, 2021

Performance of a Machine Learning Algorithm Using Electronic Health Record Data to Identify and Estimate Survival in a Longitudinal Cohort of Patients With Lung CancerQianyu Yuan, Tianrun Cai, Chuan Hong, et al.

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 3, 2021

Postdiagnosis BMI Change Is Associated with Non-Small Cell Lung Cancer SurvivalQianyu Yuan, Mulong Du, Elizabeth Loehrer, et al.

Academic Radiology|January 19, 2016

Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or GefitinibMizuki Nishino, Suzanne E Dahlberg, Linnea E Fulton, et al.

JAMA Oncology|July 9, 2016

Prospective Study of Repeated Biopsy Feasibility and Acquired Resistance at Disease Progression in Patients With Advanced EGFR Mutant Lung Cancer Treated With Erlotinib in a Phase 2 TrialAmanda J Redig, Daniel B Costa, Myriam Taibi, et al.

Cancer|September 19, 2002

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North AmericaPasi A Jänne, Boris Freidlin, Scott Saxman, et al.

Journal of the National Cancer Institute|August 27, 2021

Response to Hopkins, Kichenadasse, Logan, et alXinan Wang, Biagio Ricciuti, Joao V Alessi, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 3, 2016

Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIsJessica J Lin, Stephanie Cardarella, Christine A Lydon, et al.

Cancer Research|October 16, 2003

c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functionsPatrick C Ma, Takashi Kijima, Gautam Maulik, et al.

Journal of the National Cancer Institute|June 11, 2021

Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung CancerXinan Wang, Biagio Ricciuti, Joao V Alessi, et al.

Pageof 29

Search research articles

Showing results (71-80 of 284) with videos related to

Sort By:

Pageof 29

European Journal of Radiology|December 12, 2018

Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigmMizuki Nishino, Satoshi Wakai, Tomoyuki Hida, et al.

JAMA Network Open|July 7, 2021

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 3, 2021

Postdiagnosis BMI Change Is Associated with Non-Small Cell Lung Cancer SurvivalQianyu Yuan, Mulong Du, Elizabeth Loehrer, et al.

Academic Radiology|January 19, 2016

Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or GefitinibMizuki Nishino, Suzanne E Dahlberg, Linnea E Fulton, et al.

JAMA Oncology|July 9, 2016

Cancer|September 19, 2002

Twenty-five years of clinical research for patients with limited-stage small cell lung carcinoma in North AmericaPasi A Jänne, Boris Freidlin, Scott Saxman, et al.

Journal of the National Cancer Institute|August 27, 2021

Response to Hopkins, Kichenadasse, Logan, et alXinan Wang, Biagio Ricciuti, Joao V Alessi, et al.

Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 3, 2016

Five-Year Survival in EGFR-Mutant Metastatic Lung Adenocarcinoma Treated with EGFR-TKIsJessica J Lin, Stephanie Cardarella, Christine A Lydon, et al.

Cancer Research|October 16, 2003

c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functionsPatrick C Ma, Takashi Kijima, Gautam Maulik, et al.

Journal of the National Cancer Institute|June 11, 2021

Smoking History as a Potential Predictor of Immune Checkpoint Inhibitor Efficacy in Metastatic Non-Small Cell Lung CancerXinan Wang, Biagio Ricciuti, Joao V Alessi, et al.

Pageof 29